This article discusses the complexities of evaluating the clinical impact of in vitro diagnostic tests (IVDs) for infectious diseases, emphasizing that their effectiveness extends beyond mere accuracy. Traditional methodologies for assessing therapeutic interventions are often insufficient for diagnostics, as IVD impact depends heavily on context, implementation, and provider behavior. The authors highlight the need for advanced methodological approaches to truly capture the clinical value of these diagnostics. This includes considering downstream effects on patient management, antimicrobial stewardship, and overall healthcare outcomes, advocating for a holistic evaluation framework.
Key note: Assessing the clinical impact of infectious disease diagnostics requires methodologies beyond traditional accuracy metrics, incorporating contextual factors and downstream effects on patient care.